Diversified Healthcare Trust Common Shares of Beneficial Interest (DHC) is a publicly traded Real Estate sector company. As of November 19, 2026, DHC trades at $7.25 with a market cap of $1.74B and a P/E ratio of -4.89. DHC moved +1.26% today. Year to date, DHC is +39.86%; over the trailing twelve months it is +58.19%. Its 52-week range spans $2.00 to $9.66. Analyst consensus is buy with an average price target of $9.50. Rallies surfaces DHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for DHC, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $7.25 |
| Market Cap | $1.74B |
| P/E Ratio | -4.89 |
| EPS | $-1.55 |
| Dividend Yield | 0.01% |
| 52-Week High | $9.66 |
| 52-Week Low | $2.00 |
| Volume | 1.29M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.50B |
| Net Income | $-370.25M |
| Gross Margin | 0.00% |
3 analysts cover DHC: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.50.